Skip to main content
OpenTrials
Completed

NCT Number: NCT03105245

Understanding How Anaesthesia Affects ECT Outcomes

This study will examine how anaesthetic technique affects ECT outcomes. Specifically, the investigators will examine how: 1) the time interval between anaesthetic and ECT stimulus, and 2) the ventilation rate before ECT stimulus, impacts on the quality of the EEG (this is a recording of brain activity during ECT and is used to judge the quality of a seizure and to guide individual patient dosing).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Wesley Hospital Kogarah

Sydney, New South Wales, 2217, Australia

About this study

This study aims to examine how the time interval between administration of anaesthetic agent and ECT stimulus delivery impacts upon measures of EEG quality (seizure quality).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients treated with a course of ECT

Exclusion criteria

  • Use of non-standard anaesthetic agents in ECT (e.g. ketamine)

Treatment and study plan

Electroconvulsive Therapy (ECT) time interval + Anaesthetic (Thiopentone)

Other

The intervention in this study is the time interval between anaesthetic administration and ECT stimulus

Primary outcomes

  1. EEG Seizure Quality Rating using the EEG Seizure Quality Rating Sheet utilised by MacPherson et al

    Time frame: Outcome measures will be collected immediately after each ECT treatment from the first treatment until the end of the ECT course, an estimated total of four to six weeks for most participants

    EEG quality will be rated manually for each ECT treatment undertaken by a participant until the conclusion of their ECT course. This rating will be done using the EEG Seizure Quality Rating Sheet utilised by MacPherson et al - low dose lignocaine added to propofol does not attenuate the response to electroconvulsive therapy; Journal of Affective Disorders, 2010; 126: 330-333

Sponsors and collaborators

Lead sponsor

The University of New South Wales

Other

Collaborators

  • Wesley Mission

Registry information

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Apr 7, 2017
Registry last updated
Mar 30, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.